Heru receives CES Innovation Award for its portable diagnostic solution


[ad_1]

Heru Inc. was named a CES 2022 Innovation Awards winner in the Virtual and Augmented Reality category for re: Vive, the company’s multimodal portable diagnostic solution used to screen and diagnose visual defects.

The announcement was made ahead of the CES 2022 tech conference, which will be held January 5-8, 2022 in Las Vegas.

“On behalf of eyecare professionals around the world working for sight preservation, we are honored to receive such a prestigious award,” said Mohamed Abou Shousha, MD, PhD, Founder and CEO of Heru. “Re: Vive by Heru improves access to vision care and provides physicians with a unique, space-saving diagnostic, health and wellness tool that has revolutionized the way vision screening and diagnosis is performed in eye care.

Heru developed its re: Vive platform in partnership with the Bascom Palmer Eye Institute at the University of Miami, the leading eye hospital in the United States. The platform includes patented vision diagnostic software on commercially available AR / VR headsets. CES selected Heru’s innovative technology from a record number of entries (over 1,800) to be recognized with this year’s Innovation Award.

“Worldwide, approximately 450 million people are affected by visual defects caused by stroke, glaucoma, age-related macular degeneration and other disorders,” said Maurice R. Ferré, MD, CEO of Insightec and chairman of the board of Heru, in a statement. . “Yet the decades-old standard of care is immobile, cumbersome, expensive, and requires a trained technician or clinician to operate, limiting patients’ access to care. Limited access means millions of people with visual defects go undiagnosed, causing irreversible damage to their eyesight. Heru’s technology brings us into an era of healthcare where improving access is no longer a goal, it is the new reality.

Heru recently announced the expansion of its diagnostic platform to include three new test modalities that allow physicians to perform 6 diagnostic eye, health and wellness exams, supported with 5 codes. Refundable CPTs, in 1 portable solution. The extended platform transforms the diagnostic landscape, eliminating multiple legacy devices while providing physicians with additional reimbursement opportunities to generate revenue for their practice.

“Heru’s award-winning technology enables diagnostic exams to be performed seamlessly anywhere, even in remote locations, with clinical results available in real time, providing the ability to expand screening beyond eye care practices and traditional points of care. Kerri-Lynn Primmer Morris, chief technology officer of Microsoft, Healthcare, US Enterprises, and member of the board of directors of Heru, said in a statement.

According to the company, once patients don the portable, lightweight headset, exams are guided by Heru’s on-board virtual ‘personality’, which creates a pleasant personal experience that teaches, encourages and supports the patient throughout the process. . This frees up technicians and clinicians during the exam so they can attend to their practice, interpret clinical data, and educate patients about their treatment options.

“Visual defect screening is just the start,” said sFrederic H. Moll, MD, director of development, Johnson & Johnson Robotics, advisor and Heru investor, in a statement. “In clinical development, there are therapeutic applications that include enhanced vision correction. This cutting-edge new technology will be the first of its kind and will transform the lives of vision-impaired patients around the world. “

Owned and produced by the Consumer Technology Association (CTA), the CES Innovation Awards is an annual competition for outstanding design and engineering across 27 categories of consumer technology products. Those who have obtained the best score receive the “Best of Innovation” distinction. A panel of industry expert judges, including members of the media, designers, engineers and more, reviewed the submissions based on innovation, engineering and functionality, aesthetics and design.

[ad_2]

Comments are closed.